Hypothyroidism

Endocrinology and Metabolism Clinics of North America

Volumn 36, Issue 3, 2007, Pages 595-615

  Devdhar, Madhuri ^a   Ousman, Yasser H ^a   Burman, Kenneth D ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; LIOTHYRONINE; STEROID; THYROTROPIN; THYROXINE;

ALLERGY; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; FREE THYROXINE INDEX; HORMONE SUBSTITUTION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MONOTHERAPY; PATIENT COMPLIANCE; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REVIEW; THYROTOXICOSIS; THYROXINE BLOOD LEVEL;

COMA; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPOTHYROIDISM; MYXEDEMA; PREGNANCY; PREGNANCY COMPLICATIONS; THYROID FUNCTION TESTS; THYROXINE; TRIIODOTHYRONINE;

EID: 34547187135     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2007.04.008     Document Type: Review

References (97)

1. Vanderpump M.P. The epidemiology of thyroid diseases. In: Braverman L.E., and Utiger R.D. (Eds). The thyroid: a fundamental and clinical text. 9th edition (2004), Lippincott Williams and Wilkins, Philadelphia 398-406
2. Hollowell J.G., Staehling N.W., Flanders W.D., et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87 (2002) 489-499
3. Doeker B.M., Pfäffle R.W., Pohlenz J., et al. Congenital central hypothyroidism due to a homozygous mutation in the thyrotropin beta-subunit gene follows an autosomal recessive inheritance. J Clin Endocrinol Metab 83 (1998) 1762-1765
4. Gagné N., Parma J., Deal C., et al. Apparent congenital athyreosis contrasting with normal plasma thyroglobulin levels and associated with inactivating mutations in the thyrotropin receptor gene: are athyreosis and ectopic thyroid distinct entities?. J Clin Endocrinol Metab 83 (1998) 1771-1775
5. Collu R., Tang J., Castagne J., et al. A novel mechanism for isolated central hypothyroidism: inactivating mutations in he thyrotropin-releasing hormone receptor gene. J Clin Endocrinol Metab 82 (1997) 1561-1565
6. Weetman A.P., and McGregor A.M. Autoimmune thyroid disease: further developments in our understanding. Endocr Rev 15 (1994) 788-830
7. Mariotti S., Caturegli P., Piccolo P., et al. Antithyroid peroxidase autoantibodies in thyroid disease. J Clin Endocrinol Metab 71 (1990) 661-669
8. Nordyke R.A., Gilbert Jr. F.I., Miyamoto L.A., et al. The superiority of antimicrosomal over antithyroglobulin antibodies for detecting Hashimoto's thyroiditis. Arch Intern Med 153 (1993) 862-865
9. Endo T., Kaneshige M., Nakazato M., et al. Autoantibody against thyroid iodine transporter in the sera from patients with Hashimoto's thyroiditis possesses iodine transport inhibitory activity. Biochem Biophys Res Commun 228 (1996) 199-202
10. Bogner U., Hegedus L., Hansen J.M., et al. Thyroid cytotoxic antibodies in atrophic and goitrous autoimmune thyroiditis. Eur J Endocrinol 132 (1995) 69-74
11. Tunbridge W.M., Evered D.C., Hall R., et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 7 (1977) 481-493
12. Andersson M., Takkouche B., Egli I., et al. Current global iodine status and progress over the last decade towards the elimination of iodine deficiency. Bull World Health Organ 83 (2005) 518-525
13. Franklyn J.A., Daykin J., Drolc Z., et al. Long-term follow-up of treatment of thyrotoxicosis by three different methods. Clin Endocrinol (Oxf) 34 (1991) 71-76
14. McHenry C.R., and Slusarczyk S.J. Hypothyroidism following hemithyroidectomy: incidence, risk factors, and management. Surgery 128 (2000) 994-998
15. Sridama V., McCormick M., Kaplan E.L., et al. Long-term follow-up study of compensated low-dose 131I therapy for Graves' disease. N Engl J Med 311 (1984) 426-432
16. Hancock S.L., Cox R.S., and McDougall I.R. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 325 (1991) 599-605
17. Mercado G., Adelstein D.J., Saxton J.P., et al. Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma. Cancer 92 (2001) 2892-2897
18. Tell R., Sjodin H., Lundell G., et al. Hypothyroidism after external radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 39 (1997) 303-308
19. Pacini F., Vorontsova T., Molinaro E., et al. Prevalence of thyroid autoantibodies in children and adolescents from Belarus exposed to the Chernobyl radioactive fallout. Lancet 352 (1998) 763-766
20. Barsano C.P. Other forms of primary hypothyroidism. In: Braverman L.E., and Utiger R.D. (Eds). The thyroid: a fundamental and clinical text. 7th edition (1996), Lippincott-Raven, Philadelphia 768-778
21. Fisher D.A., and Klein A.H. Thyroid development and disorders of thyroid function in the newborn. N Engl J Med 304 (1981) 702-712
22. Brucker-Davis F., Skarulis M.C., Grace M.B., et al. Genetic and clinical features of 42 kindreds with resistance to thyroid hormone. Ann Intern Med 123 (1995) 572-583
23. Lazarus J.H. Silent thyroiditis and subacute thyroiditis. In: Braverman L.E., and Utiger R.D. (Eds). The thyroid: a fundamental and clinical text. 7th edition (1996), Lippincott-Raven, Philadelphia 577-591
24. Pearce E.N., Farwell A.P., and Braverman L.E. Thyroiditis. N Engl J Med 348 (2003) 2646-2655
25. Fatourechi V., Aniszewski J.P., Fatourechi G.Z., et al. Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study. J Clin Endocrinol Metab 88 (2003) 2100-2105
26. Gerstein H.C. How common is postpartum thyroiditis? A methodologic overview of the literature. Arch Intern Med 150 (1990) 1397-1400
27. Sakaihara M., Yamada H., Kato E.H., et al. Postpartum thyroid dysfunction in women with normal thyroid function during pregnancy. Clin Endocrinol (Oxf) 53 (2000) 487-492
28. Ruppe M.D., Huang S.A., and Jan de Beur S.M. Consumptive hypothyroidism caused by paraneoplastic production of type 3 iodothyronine deiodinase. Thyroid 15 (2005) 1369-1372
29. Wilson G.R., and Curry Jr. R.W. Subclinical thyroid disease. Am Fam Physician 72 (2005) 1517-1524
30. Ayala A., and Wartofsky L. Minimally symptomatic (subclinical) hypothyroidism. Endocrinologist 7 (1997) 44-50
31. Hamburger J.I., Meier D.A., and Szpunar W.E. Factitious elevation of thyrotropin in euthyroid patients. [letter]. N Engl J Med 313 (1985) 267-268
32. Wartofsky L., Van Nostrand D., and Burman K.D. Overt and 'subclinical' hypothyroidism in women. Obstet Gynecol Surv 61 8 (2006) 535-542
33. Parle J.V., Franklyn J.A., Cross K.W., et al. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf) 34 (1991) 77-83
34. Huber G, Mitrache C, Guglielmetti M, et al. Predictors of overt hypothyroidism and natural course: a long-term follow-up study in impending thyroid failure. 71st Annual Meeting of the American Thyroid Association. Portland (OR), 1998.
35. Kahaly G.J. Cardiovascular and atherogenic aspects of subclinical hypothyroidism. Thyroid 10 (2000) 665-679
36. Hak A.E., Pols H.A.P., Visser T.J., et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Ann Intern Med 132 (2000) 270-278
37. Bindels A.J., Westendorp R.G., Frolich M., et al. The prevalence of subclinical hypothyroidism at different total plasma cholesterol levels in middle aged men and women: a need for case-finding?. Clin Endocrinol 50 (1999) 217-220
38. Michalopoulou G., Alevizaki M., Piperingos G., et al. High serum cholesterol levels in persons with 'high normal' TSH levels: should one extend the definition of subclinical hypothyroidism. Eur J Endocrinol 138 (1998) 141-145
39. Wilson S, Parle JV, Roberts LM, et al. Prevalence of subclinical thyroid dysfunction and its relation to socioeconomic deprivation in the elderly: a community based cross-sectional survey. J Clin Endocrinol Metab 2006;12:4809-16.
40. Smith T.J., Bahn R.S., and Gorman C. Connective tissue, glycosaminoglycans, and diseases of the thyroid. Endocr Rev 10 (1989) 366-392
41. O'Brien T., Dineen S.F., O'Brien P.C., et al. Hyperlipidemia in patients with primary and secondary hypothyroidism. Mayo Clin Proc 68 (1993) 860-866
42. Hussein W.I., Green R., Jacobsen D.W., et al. Normalization of hyperhomocysteinemia with L-thyroxine in hypothyroidism. Ann Intern Med 131 (1999) 348-351
43. DeRubertis Jr. F.R., Michelis M.F., Bloom M.E., et al. Impaired water excretion in myxedema. Am J Med 51 (1971) 41-53
44. Hanna F.W., and Scanlon M.F. Hyponatraemia, hypothyroidism, and role of arginine-vasopressin. Lancet 350 (1997) 755-756
45. Kreisman S.H., and Hennessey J.V. Consistent reversible elevations of serum creatinine levels in severe hypothyroidism. Arch Intern Med 159 (1999) 79-82
46. Klein I., and Ojamaa K. Thyroid hormone and the cardiovascular system: from theory to practice. J Clin Endocrinol Metab 78 (1994) 1026-1027
47. Heymann W.R. Cutaneous manifestations of thyroid disease. J Am Acad Dermatol 26 (1992) 885-902
48. Burmeister L.A., Ganguli M., Dodge H.H., et al. Hypothyroidism and cognition: preliminary evidence for a specific defect in memory. Thyroid 11 (2001) 1177-1185
49. Siafakas N.M., Salesiotou V., and Filaditaki V. Respiratory muscle strength in hypothyroidism. Chest 102 (1992) 189-194
50. Ladenson P.W., Goldenheim P.D., and Ridgeway E.C. Prediction and reversal of blunted ventilatory responsiveness in patients with hypothyroidism. Am J Med 84 (1988) 877-883
51. Shafer R.B., Prentiss R.A., and Bond J.H. Gastrointestinal transit in thyroid disease. Gastroenterology 86 (1984) 852-855
52. Krassas G.E., Pontikides N., Kaltsas T., et al. Disturbances of menstruation in hypothyroidism. Clin Endocrinol (Oxf) 50 (1999) 655-659
53. Alexander E.K., Marqusee E., Lawrence J., et al. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 351 (2004) 241-249
54. Smallridge R.C., et al. Thyroid function inside and outside of pregnancy: what do we know and what dont we know?. Thyroid 15 (2005) 54-59
55. Burrow G.N., Fisher D.A., Larsen P.R., et al. Maternal and fetal thyroid function. N Engl J Med 331 (1994) 1072-1078
56. Glinoer D., and Delange F. The potential repercussions of maternal, fetal, and neonatal hypothyroxinemia on the progeny. Thyroid 10 10 (2000) 871-887
57. Glinoer D. Potential consequences of maternal hypothyroidism on the offspring: evidence and implications. [Review] [17 refs] [Journal Article. Review]. Horm Res 55 3 (2001) 109-114
58. Negro R., Formoso G., Mangieri T., et al. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab 91 7 (2006) 2587-2591
59. Thorpe-Beeston J.G., et al. Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus. N Engl J Med 324 (1991) 532-536
60. Glinoer D. Management of hypo- and hyperthyroidism during pregnancy. Growth Horm IGF Res 13 Suppl A (2003) S45-S54
61. Kasatkina E.P., Samsonova L.N., Ivakhnenko V.N., et al. Gestational hypothyroxinemia and cognitive function in offspring. Neurosci Behav Physiol 36 6 (2006) 619-624
62. Haddow J.E., Palomaki G.E., Allan W.C., et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 341 (1999) 549-555
63. Fish L.H., Schwartz H.L., Cavanaugh J., et al. Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism: role of triiodothyronine in pituitary feedback in humans. N Engl J Med 316 (1987) 764-770
64. Pilo A, Arvasi G, Vitek F, et al. Thyroidal and peripheral production of 3,5,3'-triiodothyronine in humans by multicompartmental analysis. Am J Physiol 258:E715-26.
65. Joint Statement on the U.S. Food and Drug Administration's decision regarding ioequivalence of levothyroxine sodium by American Thyroid Association, The Endocrine Society, and American Association of Clinical Endocrinologists.
66. Hays M.T., and Nielsen K.R.K. Human thyroxine absorption: age, effects, and methodological analyses. Thyroid 4 (1994) 55-64
67. Lamson M.J., Pamplin C.L., Rolleri R.L., et al. Quantitation of a substantial reduction in levothyroxine absorption by food. Thyroid 14 (2004) 876
68. Canaris G.J., Manowitz N.R., Mayor G., et al. The Colorado thyroid disease prevalence study. Arch Intern Med 160 (2000) 526-534
69. Bauer D.C., Ettinger B., et al. Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med 134 (2001) 561-568
70. Sawin C., Geller A., Wolf P.A., et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. [see comment] [Journal Article]. N Engl J Med 331 19 (1994) 1249-1252
71. Saravanan P., Chau W.F., Roberts N., et al. Psychological well-being in patients on 'adequate' doses of L-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol (Oxf) 57 (2002) 577-585
72. Bunevicius R., Kazanavicius G., Zalinkevicius R., et al. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med 340 (1999) 424-429
73. Walsh J.P., Shiels L., Lim E.M., et al. Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism. J Clin Endocrinol Metab 88 (2003) 4543-4550
74. Sawka A.M., Gerstein H.C., Marriot M.J., et al. Does a combination regimen of thyroxine (T4) and 3,5,3′-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial. J Clin Endocrinol Metab 88 (2003) 4551-4555
75. Clyde P.W., Harari A.E., Getka E.J., et al. Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial. JAMA 290 (2003) 2952-2958
76. Grozinsky-Glasberg S., Fraser A., Nahshoni E., et al. Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 91 (2006) 2592-2599
77. Saravanan P., Visser T.J., and Dayan C.M. Psychological well-being correlates with free thyroxine but not free 3,5,3'-triiodothyronine levels in patients on thyroid hormone replacement. J Clin Endocrinol Metab 91 9 (2006) 3389-3393
78. Grebe S.K.G., Cooke R.R., Ford H.C., et al. Treatment of hypothyroidism with once weekly thyroxine. J Clin Endocrinol Metab 82 (1997) 870
79. Glinoer D. Miscarriage in women with positive anti-tpo antibodies: is thyroxine the answer?. J Clin Endocrinol Metab 91 7 (2006) 2500-2502
80. Pop V.J., and Vulsma T. Maternal hypothyroxinaemia during (early) gestation. Lancet 365 (2005) 1604-1606
81. American College of Obstertricians and Gynecologists. ACOG practice bulletin. Clinical management guidelines for obstretician-gynecologists. No 37: thyroid disease in pregnancy. Obstet Gynecol 100 (2002) 387-396
82. Surks M.I. Subclinical thyroid dysfunction: a joint statement on management from the American association of clinical endocrinologists, the American thyroid association and the endocrine society. J Clin Endocrinol Metab 90 (2005) 586-587
83. Spong C.Y. Subclinical hypothyroidism: should all pregnant women be screened?. Obstet Gynecol 105 (2005) 235-236
84. Pinchera A. Subclinical thyroid disease: to treat or not to treat?. Thyroid 15 (2005) 1-2
85. Baloch Z., Carayon P., Conte-Devolx B., et al. Guidelines committee, national academy of clinical biochemistry. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13 (2003) 3-126
86. Baskin H.J., Cobin R.H., Duick D.S., et al. American association of clinical endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 8 (2002) 457-469
87. Surks M.I., Ortiz E., Daniels G.H., et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291 (2004) 228-238
88. Jorde R., Waterloo K., Storhaug H., et al. Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment. J Clin Endocrinol Metab 91 (2006) 145-153
89. Milionis H.J., Tambaki A.P., Kanioglou C.N., et al. Thyroid substitution therapy induces high density lipoprotein-associated platelet-activating factor acetylhydrolase in patients with subclinical hypothyroidism: a potential antiatherogenic effect. Thyroid 15 (2005) 455-460
90. Caraccio N., Natali A., Sironi A., et al. Muscle metabolism and exercise tolerance in subclinical hypothyroidism: a controlled trial of levothyroxine. J Clin Endocrinol Metab 90 (2005) 4057-4062
91. Brenta G., Mutti L.A., Schnitman M., et al. Assessment of left ventricular diastolic function by radionuclide ventriculography at rest and exercise in subclinical hypothyroidism, and its response to thyroxine therapy. Am J Cardiol 91 (2003) 1327-1330
92. Ord W.M. On myxedema, a term proposed to the be applied to an essential condition in the cretinoid affection occasionally observed in middle-aged women. Med Chir Trans 61 (1878) 57-78
93. Rodriguez I., Fluiters E., Perez-Mendez L.F., et al. Factors associated with mortality of patients with myxoedema coma: prospective study in 11 cases treated in a single institution. J Endocrinol 180 2 (2004) 347-350
94. Solano Jr. F.X., Starling R.C., and Levey G.S. Myxedema megacolon. Arch Intern Med 145 2 (1985) 231
95. Chernow B., Burman K.D., Johnson D.L., et al. T3 may be a better agent than T4 in the critically ill hypothyroid patient: evaluation of transport across the blood-brain barrier in a primate model. [Journal Article]. Crit Care Med 11 2 (1983) 99-104
96. Holvey D.N., Goodner C.J., Nicoloff J.T., et al. Treatment of myxedema coma with intravenous thyroxine. Arch Intern Med 113 (1964) 89-96
97. Yamamoto T., Fukuyama J., and Fujiyoshi A. Factors associated with mortality of myxedema coma: report of eight cases and literature survey. Thyroid 9 12 (1999) 1167-1174